News

Continuity of respiratory care during COVID-19 - Continuous Respiratory Monitoring with Hexoskin

Patients suffering from lung diseases such as Chronic Obstructive Pulmonary Disease (COPD) are among the most vulnerable to infections, including the Coronavirus disease (SARS-CoV-2). In fact, they are more likely to develop severe disease or to be admitted to intensive care units (ICU) when compared to patients with conditions like high blood pressure or diabetes (Jain et al. 2020). COPD patients also have a 5 fold greater risk of developing complications when contracting SARS-CoV-2 (Lippi et al. 2020). In fact, COPD patients are at risk of developing a more severe form of SARS-CoV-2 leading to serious complications (Attaway et al. 2020). Overall, the care management may turn out to be far more complicated for these patients (Tal-Singer et al. 2020).

The importance of ensuring continuity of care for lung diseases & COPD Patients

The number of COPD patients has been on the rise for several decades already and are projected to keep increasing (Adeloye et al. 2015; GlobalData 2018; Ma et al. 2015). Comorbidities and complications associated with this chronic condition make this the highest financial burden on the healthcare system (Chapman et al. 2006; Ford et al. 2015). In the current COVID-19 context, these costs may increase dramatically.

This alarming rate of COPD patients requiring continuous and expensive medical care is now combined with the pressure faced by Healthcare systems to tackle  the COVID-19 pandemic. It has become essential to think of cost-effective tools such as connected health platforms and telemedicine services for assisting and monitoring these patients at home (Tal-Singer et al. 2020). It was even reported that some COPD patients were misdiagnosed for SARS-CoV-2,  thus delaying proper care and putting them in a precarious situation (Tal-Singer et al. 2020). Imperative actions must be implemented to closely monitor all COPD patients, ensure the continuity of their care and prevent disease progression, exacerbations and further harm. Acting early and effectively towards this most vulnerable population will be the key to good clinical outcomes and lower medical costs for the healthcare system.

Throughout the COVID-19 pandemic, Hexoskin remains committed to providing complete connected health solutions for remote patient monitoring, thereby promoting efficient and valuable continuity of care. Hexoskin is the only clinically validated garment able to provide continuous vital signs monitoring and has already been widely used in both clinical and scientific research settings (over 85 scientific publications). Integrating new and innovative technologies such as Hexoskin into the basic care of patients with chronic respiratory diseases will ensure an enhanced and continuous assessment of their health condition, and this, at all times.

Figure 1. Optimizing patient care with continuous monitoring with Hexoskin.

How to remotely and continuously monitor patients with respiratory diseases & COPD with Hexoskin?

To learn more about how to remotely and continuously monitor patients with respiratory diseases & COPD with Hexoskin, we invite you to download our latest White Paper. In this White Paper, you will learn more about: 

• Hexoskin’s unique capabilities to continuously monitor, not only respiratory rate, but the overall respiratory function.
• Easing patient burden and improving their overall experience outcome using the Hexoskin Remote Monitoring Platform
• How Hexoskin telemonitoring solution for COPD patients and other respiratory diseases contribute to Patient empowerment and improvement of Quality of Life.

Join us this week at #BIODigital International Convention 2020!

Hexoskin is thrilled to attend once again the upcoming BIODigital International Convention 2020, and connect with other members of the life science community. This year the meetings will transition to a virtual event format in which Hexoskin will take part. Pierre-Alexandre Fournier, co-founder, and CEO of Hexoskin will speak on the panel:

Can AI Prevent Epidemics? (Available on demand).

The panel is hosted by Annastasiah Mudiwa Mhaka, PhD, Co-founder and Convenor of the Alliance for Artificial Intelligence in Healthcare (AAIH) Convenor, former President; Founder; Mawambo Lifesciences. Our CEO will be joined in this panel by leaders in government, technology, venture capital, and health care to discuss the potential for using AI to protect us from the next pandemic or superbug. The world is more vulnerable than ever to outbreaks and remains ill-prepared to predict, prevent, detect, and respond to a significant pandemic. The panel will cover how advancements in artificial intelligence (AI) and machine learning (ML) tools and algorithms can improve the prediction of infectious disease outbreaks and prevent them from causing devastating pandemics. The panel participants will also discuss the kind of innovative public-private partnerships that can be used to develop and test new AI tools for epidemic prevention. 

Hexoskin will also demonstrate how the industry can leverage Hexoskin sensors, clinical solutions, and AI to fulfill the increasing demand for real-world evidence. Pharma and CROs interested in digital biomarkers are invited to reach out to our team to get insights on how clinical-grade wearable sensors and AI software can facilitate remote trials and monitor patients from home.

A CONNECTED HEALTH PLATFORM BUILT AROUND
YOU AND THE PATIENT

Hexoskin is the world leader in smart clothing and body sensing technologies.

The Hexoskin Connected Health Platform is the fastest growing platform available to collect Real World Evidence and publish results. Hexoskin is the leading clinically validated solution that collects continuously precise ECG, Respiratory & Activity & Sleep data.

Thousands of professionals, researchers, and students from universities, research institutions, colleges, and private organizations are leveraging the precise data collected by our comfortable and non-invasive Smart Garments. Our clients appreciate our accessible solutions such as the Hexoskin Dashboards, Open API, and Apps to manage, visualize, analyze, and export raw & processed data.

With over 85 scientific publications & validation studies published since 2012, Hexoskin is the solution of choice to generate precise physiological health data. Hexoskin’s team of experts supports researchers and investigating teams to design and manage their multi-sites studies.

Request an e-meeting with our team to discuss your needs and learn more about how Hexoskin can support remote patient-centered studies. 

 

@Hexoskin is thrilled to attend once again the BIO International Convention this week. @pafournier, co-founder, and CEO of Hexoskin will speak on the panel: Can AI Prevent Epidemics? (Available on demand).https://t.co/oF1Q2e5tYX pic.twitter.com/xuV5oSzVWp

— Hexoskin - Sensors & AI (@Hexoskin) June 9, 2020

Hexoskin Celebrates Pulmonary Rehabilitation Week

Today, we start celebrating Pulmonary Rehabilitation Week. At Hexoskin, we think that Pulmonary Rehabilitation (PR) is vital and we are happy to celebrate all the efforts of the professionals and also the people who are following a PR. Pulmonary Rehabilitation programs have demonstrated health benefits and can positively improve the quality of life of people living with lung diseases.

If you have moderate to very severe Chronic obstructive pulmonary disease (COPD), you're probably eligible for pulmonary rehab. Ask your physician if there's a program near you.

For healthcare professionals, did you know that PR referrals & access are still very limited? According to a recent study, only 3% of Medicare beneficiaries with COPD are currently enrolled (Garvey et al. 2019). You can do your part by educating your peers, colleagues, and administrators about the benefits of PR.

For more information, visit the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) Website: https://www.aacvpr.org/Events-Education/Live-Workshops/Cardiac-Pulmonary-Rehabilitation-Weeks

#PRWeek20

This week is Pulmonary Rehabilitation Week! 🌬️🌬️🌬️

If you have moderate to very severe chronic obstructive pulmonary disease (COPD), you're probably eligible for pulmonary rehab. Ask your physician if there's a program near you.#PRWeek20https://t.co/4sjgq4eV0M

— Hexoskin - Sensors & AI (@Hexoskin) March 9, 2020

Hexoskin: The Leading Platform for Health Research. Get 10% OFF + FREE SHIPPING Today!

With over 83 scientific publications, the Hexoskin Connected Health Platform is the fastest growing platform available to collect Real World Evidence and publish results. Hexoskin is the only clinically validated solution that collects continuously precise ECG, Respiratory & Activity & Sleep data.

Thousands of professionals, researchers, and students from universities, research institutions, colleges, and private organizations are leveraging the precise data collected by our comfortable and non-invasive Smart Garments. Our clients appreciate our accessible solutions such as the Hexoskin Dashboards, Open API, and Apps to manage, visualize, analyze, and export raw & processed data.

Get 10% OFF + FREE SHIPPING on Your Hexoskin Order

For a limited time*, Hexoskin offers a 10% Discount and FREE Shipping* on all Hexoskin Smart Garments & Kits. To order, contact sales@hexoskin.com or call our Sales team at 1 888-887-2044. Mention the code HEXOPRO to qualify for the discount.

This is a limited time offer* only valid until March 31, 2020, at 11:59 PM (EST). 

About Hexoskin:
Founded in 2006 in Montreal, Hexoskin is the leader in non-invasive sensors, smart clothing, software, data science & AI services. Hexoskin launched in 2013 the first washable smart shirts that capture cardiac, respiratory, and activity body metrics. The Hexoskin platform is an end-to-end software system to monitor and analyse users' general health, vital signs, sleep, and activity, using built-in sensors embedded in smart garments made in Canada.

The Hexoskin smart clothing and Hexoskin Connected Health Platform has been used to collect data for over 80 scientific publications in the fields of cardiology, respiratory, behavioural & physiological psychology, sleep patterns, circadian rhythms, effects of aging on physical performance, and AI-Machine Learning.

Hexoskin End of Year Retrospective

This year has been great for Hexoskin and our users! Looking back, 2019 was one the most innovative and exciting year we had yet. We thought it would be great to do a retrospective of a few milestones!

Every day at Hexoskin, we aim to address today's and tomorrow’s health challenges. We launched this year 5 new state-of-the-art tools for researchers & professionals that are pushing the boundaries of health research every day:

• We made the Hexoskin Connected Health Platform available to fully support remote patient monitoring and physiological data visualization and analysis.
• We released the new Hexoskin Dashboard for health monitoring, data reporting, and sharing.
• We launched the widely acclaimed Hexoskin ProShirt line of smart garments which boasts an all-new design to monitor a wide range of daily activities. 
• We developed the Astroskin Vitals Signs Monitoring Platform as a tool to promote enhanced physiological assessments on Earth & in Space.
• The Hexoskin SDK for Android is now available for our community of developers to create groundbreaking health-related apps on Android Smartphones.

Today, the Hexoskin Connected Health Platform is a complete end-to-end solution that offers leading-edge sensors, software, and data science tools. Here is a quick summary of some of the great achievements of Hexoskin and our clients this year:

• Hexoskin took part in pioneering clinical studies aimed at monitoring patients living with COPD and young children living with rare diseases from the comfort of their home.
• Hexoskin monitored Cadets and Police Officers during their training & operations to study how Operational Stress Injury (OSI) occur and prevent the development of Post-Traumatic Stress Disorder (PTSD).
• Hexoskin is involved in a first-of-its-kind five-year project, building the world’s largest database of vital signs data from patients suffering from Myalgic Encephalomyelitis (ME) (Chronic Fatigue).
• The Hexoskin Connected Health Platform is part of cutting edge study on sleep, performance, and young athletes with FC Barcelona and Allianz, that will leverage our understanding of young athletes' health development and performance.
• Our team is contributing to the Alliance for Artificial Intelligence in Healthcare reflection that will drive the future of AI development in healthcare.
• Hexoskin's clinically validated smart garments have now been used in 83 scientific publications. 
• Astroskin continuously monitored the first person having completed a lightning ascent of Mount Everest in 14 days, thereby gathering unequivocal data on how the human body adapts to high altitude hypoxia.
• Astroskin / Bio-Monitor System commissioning phase was successfully completed on the International Space Station by Canadian Astronaut David Saint-Jacques. 
• Italian Astronaut Luca Parmitano launched phase I of a leading Cardiovascular Aging Research in Space and made the system operational for the next five years to all participating countries to conduct space medicine research on the ISS On-Orbit Lab. 
• Visit the Hexoskin News page to learn more about Hexoskin's new products & services, ongoing Projects & Research. We can't wait to show you what we have in the works for 2020!

Harness the Power of Hexoskin Connected Health Platform!

Before you start planning your project, contact us to learn more about how Hexoskin can support you. 

Celebrating World COPD Day: Actions & Awareness for COPD

Today is COPD day. World Chronic Obstructive Pulmonary Disease Day (COPD) is celebrated on the third Wednesday of November every year, in collaboration with health experts, research foundations and patients with COPD.

COPD is not one single disease but an umbrella term used to describe chronic lung diseases that cause limitations in lung airflow. COPD is a life-threatening disease in advanced cases. It is an under-diagnosed and life-threatening lung disease, leading cause of death in the United States, affecting 16 million Americans and millions more who don’t know they have it. 

Help support research and education by giving to the COPD Foundation that undertakes daily initiatives to improve the lives of individuals affected by COPD, and expand care services for COPD. The Foundation’s activities focus on achieving these results through education and advocacy programs and research that will lead to prevention, and someday, a cure for this disease.

Allianz Partners: "Hexoskin – a smart t-shirt capable of monitoring lung diseases".

Allianz Parters just published an article "Hexoskin – a smart t-shirt capable of monitoring lung diseases.

Back in 2013, Hexoskin launched a unique solution that revolutionized how we monitor cardiac, respiratory, activity, and sleep data with sensors embedded in a comfortable and machine washable smart garment. Today, the Hexoskin Connected Health Platform is an end-to-end solution that offers leading-edge sensors, software, and data science tools. It is used by researchers, public and private organizations, athletes, and users who value precise, accessible, and useful health data.

Thousands of professionals & researchers around the world are using the Hexoskin Connected Health Platform for Health research, Clinical development, First Response & Defense, Aeronautics & Space projects, Sports & Performance applications. Our user base is growing at a fast pace and uses Hexoskin in several Therapeutic Areas such as Cardiology, Respiratory, Neurology, Mental Disorders, and Pediatrics to name a few. 

Read more at: https://allianzpartners-bi.com/news/hexoskin-a-smart-t-shirt-capable-of-monitoring-lung-diseases-606c-333d4.html

The Hexoskin Connected Health Platform offers Body-Worn Sensors, Software Solutions, and Data Analytics to support projects of any sizes in order to change how patients receive care. 

Hexoskin is attending this week the Québec Respiratory Health Congress in Montréal.

Hexoskin is attending this week the Québec Respiratory Health Annual Congress (Congrès Québécois en Santé Respiratoire) of the Quebec Lung Association, on October 24 & 25, 2019 at the Montréal Science Center.

The Hexoskin team will meet with specialists, researchers and many stakeholders in Respiratory and Pulmonary Health. Our team will present its Connected Health Platform and its expertise for remote monitoring of patients with respiratory diseases from the comfort of their homes.

At Hexoskin, we're committed to work with organizations like the Québec Lung Association (APQ), American College of Chest Physicians, American Thoracic Society (ATS), COPD Foundation, the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), the American Heart Association (AHA), the Alliance for Artificial Intelligence in Healthcare (AAIH) and many others to develop new standards of care for these chronic patients.

If you're a Pharma, a Medical company or a Healthcare provider interested in patient remote monitoring with digital markers, sensors, and AI, please contact us.

About Hexoskin
Founded in 2006 in Montreal, Hexoskin (Carré Technologies) is involved in the development of non-invasive sensors, software and applications, data science services and AI. Hexoskin's mission is to record and categorize personal health information, to make it accessible and useful.

Hexoskin takes part in the AAIH reflection about Artificial Intelligence in Healthcare

The Alliance for Artificial Intelligence in Healthcare (AAIH) just published a white paper titled "A Primer on AI in Healthcare".

The Primer on AI in Healthcare attempts to cover many uses for AI in healthcare in a way that is accessible, but also as precise and concrete as possible. We hope this document will serve as a reference for future discussions and publications for all stakeholders in healthcare and AI, including patients and providers.

A Primer on Artificial Intelligence in Healthcare - A technical introduction
The 45-page document describes AI approaches and applications in healthcare and biopharma research, and helps introduce standard definitions for the industry.

The Hexoskin Team is proud to have taken part in this reflection that will drive the future of AI development for Connected Health in healthcare.

"It was important for me to contribute to this essential white paper. There was a need to clarify terms and concepts in AI with an emphasis on applications in healthcare, biomedical discovery, clinical development, and home care". Pierre-Alexandre-Fournier - CEO at Hexoskin.

Hexoskin is Attending Chest Annual Meeting in New Orleans On October 19-23, 2019.

Hexoskin is attending the Chest Annual Meeting on October 19-23, 2019 in New Orleans.

The Hexoskin Team will be meeting with Chest Physicians and multiple stakeholders from Lung Health and Clinical Chest Medicine. Our team will showcase its Connected Health Platform and expertise for monitoring patients with chronic respiratory & cardiac diseases remotely, from the comfort of their home.

If your company is interested in digital markers, sensors and AI in healthcare, book a meeting with our team y contacting us.